Posted September 17, 2019
Balko JM, Mayer IA, Sanders ME, Miller TW, Kuba MG, Wagle N, Garraway LA, Arteaga CL. Discordant cellular response to presurgical letrozole in bilateral synchronous ER+ breast cancers with a KRAS mutation or FGFR1 gene amplification. Mol Cancer Ther. 2012 Oct;11(10):2301-5.